Liza-Marie Johnson, MD
Liza-Marie Johnson, MD, MPH, MSB

Liza-Marie Johnson, MD, MPH, MSB

Assistant Member, St. Jude Faculty

  • Program Director, Oncology Hospitalist Medicine
  • Bioethics Consultant (Clinical & Research Consultations)

Departments

Divisions

Education

BA – Vassar College
MPH – Tulane School of Public Health & Tropical Medicine
MD
– Tulane School of Medicine
MSB – Union Graduate College (now Clarkson University)

Internship/Residency – Tufts Medical Center, Boston, MA
Fellowship (Pediatric Hematology/Oncology) – St. Jude Children’s Research Hospital

Honors & Awards

  • 2015 National Institutes of Health, OBSSR/NHLBI Summer Institute Award Recipient
  • 2014 National Institutes of Health, Loan Repayment Program Award Recipient
  • 2012 American Academy of Hospice and Palliative Medicine Research Scholar

Research Interests

  • Communication and decision making in pediatric oncology
  • Ethical issues in genomic sequencing in pediatrics
  • Clinical ethics consultation in pediatrics
  • Research ethics
  • Quality improvement in ambulatory/urgent care pediatric oncology

Selected Publications

Johnson LM, Torres C, Sykes A, Gibson DA, Baker JN. Peer Loss Due to Death Increases Risk of Adverse Psychological Outcomes in Adolescents and Early Young Adults with Cancer. Plos One 2017 (in press).

Johnson LM, Hamilton KV, Valez JM, Knapp K, Baker JN, Nichols KE. Ethical Considerations Surrounding Germline Next Generation Sequencing of Children with Cancer. Expert Review of Molecular Diagnostics May;17(5):523-534, 2017. PMID: 28399664

Johnson LM, Frader J, Wolfe J, Baker JN, Anghelescu D, Lantos JD. Ethics Rounds: Palliative Sedation with Propofol for an Adolescent with a DNR Order. Pediatrics Aug;140(2), 2017. PMID: 28679640

Anghelescu DL, Knapp E, Johnson LM, Baker JN. The Role of The Pediatric Anesthesiologist in Relieving Suffering at the End of Life: When is Palliative Sedation Appropriate in Pediatrics? Pediatric Anesthesia Apr;27(4):443-444 2017. PMID: 28300355

Johnson LM, Valdez JM, Quinn E, Sykes A, McGee R, Nuccio R, Hines-Dowell S, Baker JN, Kesserwan C, Nichols KE, Mandrell B. Integrating Next Generation Sequencing into Pediatric Oncology Practice: An Assessment of Physician Confidence and Understanding of Clinical Genomics. Cancer 123(12):2352-2359 2017. PMID: 28192596

Nickels AS, Myers GD, Johnson LM, Joshi A, Sharp RR, Lantos JD. Ethics Rounds: Can Parents Refuse a Potentially Life-Saving Transplant for Severe Combined Immunodeficiency? Pediatrics July;138(1), 2016. PMID: 27307145

Levine DR, Johnson LM, Wiser RK, Gibson D, Kane JR, Baker JN. Integrating Palliative Care in Pediatric Oncology: An Evolving Paradigm at St Jude Children’s Research Hospital. Journal of National Comprehensive Cancer Network June;14(6):741-8, 2016. PMID 27283167.

Johnson LM, Unguru Y. Recruiting Children for Clinical Trials: Lessons from Pediatric Oncology. Am J Bioeth 15(11):24-26, 2015.

Johnson LM, Leek AC, Drotar D, Noll RB, Rheingold SR, Kodish ED, Baker JN. Practical Communication Guidance to Improve Phase I Informed Consent Conversations and Decision-Making in Pediatric Oncology. Cancer 121(14):2439-48, 2015.

Johnson LM, Church CL, Metzger M, Baker JN. Ethics Consultation in Pediatrics: Long-Term Experience from a Pediatric Oncology Center. Am J Bioeth 15(5):3-17, 2015.

Weaver M, Johnson LM. International Child Health Competencies. JAMA Pediatr 169(7):621-622, 2015.

Baker JN, Levine DR, Hinds PS, Weaver MS, Cunningham MJ, Johnson LM, Anghelescu D, Mandrell B, Gibson DV, Jones B, Wolfe J, Feudtner C, Freibert S, Carter B, Kane JR. Research Priorities in Pediatric Palliative Care. J Pediatr 167(2):467-70.e3, 2015.

Johnson LM and Sanchez AM (co-first authors), Kane JR, Kasow KA, Quintana Y, Barfield R, Church CL, Hester M, Baker JN. Ethical Decision Making About End-of-life Care Issues by Pediatric Oncologists in Economically Diverse Settings. J Pediatr Hematol Oncol 37(4):257-63, 2015.

Levine DR, Johnson LM, Mandrell B, Yang J, West N, Hinds PS, Baker JN. Does phase 1 trial enrollment preclude quality end‐of‐life care? Phase 1 trial enrollment and end‐of‐life care characteristics in children with cancer. Cancer 121(9):1508-1512, 2015.

Zaidi A, Johnson LM, Church CL, Gomez-Garcia WC, Popescu M, Margolin J, Ribeiro R. Management of Concurrent Pregnancy and Acute Lymphoblastic Malignancy in Teenaged Patients. Two Illustrative Cases and Review of the Literature. J Adolesc Young Adult Oncol 3(4):160-175, 2014.

Johnson LM, Snaman JM, Cupit MC, Baker JN. Review Article: End of Life Care for Hospitalized Children. Pediatr Clin North Am 61(4):835-854, 2014.

Johnson LM, Levine D. Allocation of Drugs in Short Supply. Virtual Mentor 15:645-648, 2013.

Johnson LM, Feudtner C, Baker JN. Minimally Conscious Assumptions and Dangerous Decision-making Inferences. AJOB Neurosci 4(1):61-63, 2013. 

Johnson LM, Church CL, Walsh M, Baker JN. Clinically Significant? Depends Who You Ask. Am J Bioeth (10):18-20, 2012.

Anghelescu DL, Hamilton H, Faughnan LG, Johnson LM, and Baker JN.  Pediatric Palliative Sedation Therapy with Propofol: Recommendations Based on Experience in Children with Terminal Cancer. J Palliat Med 15(10):1082-90, 2012.

Johnson LM, Spraker HL, Coleman JL, Baker JN. An unusual case of Ogilvie Syndrome in a pediatric oncology patient with progressive incurable cancer who failed treatment with neostigmine. J Palliat Med 15(9):1042-6, 2012.

Last update: August 2017